Administrative Unit for the GLIA-CTN

GLIA-CTN 行政单位

基本信息

项目摘要

Abstract The GLIA-CTN Administrative Unit will coordinate all consortium activities and finances and will set general policies and procedures in collaboration with the RDCRN and Office of Rare Disorders (ORD)/ National Institutes of Child Health and Development (NICHD). In addition, the Unit will serve as the administrative center for the Data Integration Core of the Consortium, to centralize the ability of the GLIA-CTN to collect from and deliver data to relevant stakeholders, including the RDCRN DMCC, patient advocacy partners and industry collaborators. The Administrative Unit will also be responsible for all regulatory activities of GLIA: ongoing evaluation of productivity at sites; oversight of all projects including pilot projects; and oversight of the career development program. In addition, the Unit will be responsible for NIH and federal compliance, such as implementation of regulatory activities, observance of NIH and federal policies regarding human subject protections, Health Insurance Portability and Accountability Act (HIPAA) stipulations, and the inclusion of women, minorities and children. Details of implementation within the Administrative Unit are described below and include the chain of command for decision-making and administration, the reporting structure, the communication plan, as well as for the overall integration of GLIA with RDCRN activities. This component describes the key roles of the Administrative Unit, as well as the governance of the GLIA-CTN, the use of a Data Integration Core, all committees and the mechanisms for collaboration with the patient advocacy groups.
摘要 GLIA-CTN行政单位将协调所有联合体活动和财务,并将制定一般 与RDCRN和罕见疾病办公室(ORD)/国家 儿童健康与发展研究所(NICHD)。此外,该股还将作为行政管理股, 联合体数据集成核心中心,集中GLIA-CTN收集 从相关的利益相关者,包括RDCRN DMCC,患者倡导合作伙伴和 行业合作者。行政股还将负责GLIA的所有监管活动: 对各地点的生产力进行持续评估;监督所有项目,包括试点项目;监督 职业发展计划。此外,该单位将负责NIH和联邦的合规性, 例如实施管理活动、遵守NIH和联邦关于人类健康政策 受试者保护,健康保险流通和责任法案(HIPAA)规定,以及 包括妇女、少数民族和儿童。行政组内的实施细节如下: 包括决策和管理的指挥系统,报告 这是一个非常重要的问题,它包括结构、沟通计划以及GLIA与RDCRN活动的整体整合。这 组成部分描述了行政单位的关键作用,以及GLIA-CTN的治理, 使用数据集成核心、所有委员会和与患者协作的机制 倡导团体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adeline Lucie Vanderver其他文献

Adeline Lucie Vanderver的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adeline Lucie Vanderver', 18)}}的其他基金

GLIA-CTN Genomic Expert Curation Panel
GLIA-CTN 基因组专家管理小组
  • 批准号:
    10630404
  • 财政年份:
    2023
  • 资助金额:
    $ 18.68万
  • 项目类别:
Reverse transcriptase inhibition as a novel therapeutic approach for ADAR-1-related Aicardi Goutières Syndrome
逆转录酶抑制作为 ADAR-1 相关 Aicardi Goutières 综合征的新型治疗方法
  • 批准号:
    10288270
  • 财政年份:
    2022
  • 资助金额:
    $ 18.68万
  • 项目类别:
Improved clinical and biologic outcome measures in Aicardi Goutieres Syndrome
改善 Aicardi Goutieres 综合征的临床和生物学结果测量
  • 批准号:
    10675475
  • 财政年份:
    2019
  • 资助金额:
    $ 18.68万
  • 项目类别:
Optimizing Trial Readiness for Adrenomyeloneuropathy
优化肾上腺脊髓神经病的试验准备
  • 批准号:
    10675464
  • 财政年份:
    2019
  • 资助金额:
    $ 18.68万
  • 项目类别:
Career Enhancement Core of GLIA-CTN
GLIA-CTN 职业提升核心
  • 批准号:
    10023214
  • 财政年份:
    2019
  • 资助金额:
    $ 18.68万
  • 项目类别:
Improved clinical and biologic outcome measures in Aicardi Goutieres Syndrome
改善 Aicardi Goutieres 综合征的临床和生物学结果测量
  • 批准号:
    10023212
  • 财政年份:
    2019
  • 资助金额:
    $ 18.68万
  • 项目类别:
Optimizing Trial Readiness for Adrenomyeloneuropathy
优化肾上腺脊髓神经病的试验准备
  • 批准号:
    10442670
  • 财政年份:
    2019
  • 资助金额:
    $ 18.68万
  • 项目类别:
Improved Outcome Assessments in Adrenomyeloneuropathy
改进肾上腺脊髓神经病的结果评估
  • 批准号:
    10675469
  • 财政年份:
    2019
  • 资助金额:
    $ 18.68万
  • 项目类别:
: Clinical Outcomes in Aicardi Goutières Syndrome
: Aicardi Goutières 综合征的临床结果
  • 批准号:
    10459505
  • 财政年份:
    2019
  • 资助金额:
    $ 18.68万
  • 项目类别:
Administrative Unit for the GLIA-CTN
GLIA-CTN 行政单位
  • 批准号:
    10923620
  • 财政年份:
    2019
  • 资助金额:
    $ 18.68万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 18.68万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 18.68万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.68万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.68万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.68万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 18.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 18.68万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 18.68万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 18.68万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 18.68万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了